{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T22:43:28Z","timestamp":1790981008398,"version":"4.1.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11926-025-01199-4","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T10:18:53Z","timestamp":1753870733000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Quality Care Assessment in Gout"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0354-4794","authenticated-orcid":false,"given":"Timothy S.H.","family":"Kwok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2260-4079","authenticated-orcid":false,"given":"Priyanka","family":"Chandratre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,30]]},"reference":[{"key":"1199_CR1","doi-asserted-by":"publisher","first-page":"33082","DOI":"10.1038\/srep33082","volume":"6","author":"S Li","year":"2016","unstructured":"Li S, Yang H, Guo Y, Wei F, Yang X, Li D, et al. Comparative efficacy and safety of urate-lowering therapy for the treatment of hyperuricemia: a systematic review and network meta-analysis. Sci Rep. 2016;6:33082.","journal-title":"Sci Rep"},{"key":"1199_CR2","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1177\/2040622315618393","volume":"7","author":"JA Bernal","year":"2016","unstructured":"Bernal JA, Quilis N, Andr\u00e9s M, Sivera F, Pascual E. Gout: optimizing treatment to achieve a disease cure. Ther Adv Chronic Dis. 2016;7:135\u201344.","journal-title":"Ther Adv Chronic Dis"},{"key":"1199_CR3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jaut.2009.02.006","volume":"32","author":"R Eisenberg","year":"2009","unstructured":"Eisenberg R. Why can\u2019t we find a new treatment for SLE? J Autoimmun. 2009;32:223\u201330.","journal-title":"J Autoimmun"},{"key":"1199_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1136\/annrheumdis-2020-217344","volume":"80","author":"G Nagy","year":"2021","unstructured":"Nagy G, Roodenrijs NM, Welsing PM, Kedves M, Hamar A, van der Goes MC, et al. EULAR definition of difficult-to-treat rheumatoid arthritis. Ann Rheum Dis. 2021;80:31\u20135.","journal-title":"Ann Rheum Dis"},{"key":"1199_CR5","doi-asserted-by":"publisher","first-page":"e003809","DOI":"10.1136\/rmdopen-2023-003809","volume":"10","author":"S Singla","year":"2024","unstructured":"Singla S, Ribeiro A, Torgutalp M, Mease PJ, Proft F. Difficult-to-treat psoriatic arthritis (D2T PsA): a scoping literature review informing a GRAPPA research project. RMD Open. 2024;10:e003809.","journal-title":"RMD Open"},{"key":"1199_CR6","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1093\/rheumatology\/kex530","volume":"57","author":"SK Rai","year":"2018","unstructured":"Rai SK, Choi HK, Choi SHJ, Townsend AF, Shojania K, De Vera MA. Key barriers to gout care: a systematic review and thematic synthesis of qualitative studies. Rheumatol Oxf Engl. 2018;57:1282\u201392.","journal-title":"Rheumatol Oxf Engl"},{"key":"1199_CR7","first-page":"498","volume":"35","author":"E Krishnan","year":"2008","unstructured":"Krishnan E, Lienesch D, Kwoh CK. Gout in ambulatory care settings in the united States. J Rheumatol. 2008;35:498\u2013501.","journal-title":"J Rheumatol"},{"key":"1199_CR8","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s11999-015-4511-7","volume":"474","author":"BF DiGiovanni","year":"2016","unstructured":"DiGiovanni BF, Sundem LT, Southgate RD, Lambert DR. Musculoskeletal medicine is underrepresented in the American medical school clinical curriculum. Clin Orthop. 2016;474:901\u20137.","journal-title":"Clin Orthop"},{"key":"1199_CR9","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1186\/s12909-024-05849-6","volume":"24","author":"J Peeler","year":"2024","unstructured":"Peeler J. Addressing musculoskeletal curricular inadequacies within undergraduate medical education. BMC Med Educ. 2024;24:845.","journal-title":"BMC Med Educ"},{"key":"1199_CR10","doi-asserted-by":"publisher","first-page":"105919","DOI":"10.1016\/j.jbspin.2025.105919","volume":"92","author":"TSH Kwok","year":"2025","unstructured":"Kwok TSH, Bajaj S, Papneja T, Ahluwalia V, Choy G, Joshi R. Diagnostic accuracy and trajectories of referrals for gout to rheumatology. Joint Bone Spine. 2025;92:105919.","journal-title":"Joint Bone Spine"},{"key":"1199_CR11","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.semarthrit.2015.02.004","volume":"45","author":"SK Rai","year":"2015","unstructured":"Rai SK, Burns LC, De Vera MA, Haji A, Giustini D, Choi HK. The economic burden of gout: A systematic review. Semin Arthritis Rheum. 2015;45:75\u201380.","journal-title":"Semin Arthritis Rheum"},{"key":"1199_CR12","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1093\/rheumatology\/ket265","volume":"52","author":"P Chandratre","year":"2013","unstructured":"Chandratre P, Roddy E, Clarson L, Richardson J, Hider SL, Mallen CD. Health-related quality of life in gout: a systematic review. Rheumatol Oxf Engl. 2013;52:2031\u201340.","journal-title":"Rheumatol Oxf Engl"},{"key":"1199_CR13","doi-asserted-by":"crossref","unstructured":"Vargas-Santos AB, Neogi T, da, Castelar-Pinheiro R, Kapetanovic G, Turkiewicz MC. A. Cause-Specific Mortality in Gout: Novel Findings of Elevated Risk of Non-Cardiovascular-Related Deaths. Arthritis Rheumatol Hoboken NJ. 2019;71:1935\u201342.","DOI":"10.1002\/art.41008"},{"key":"1199_CR14","doi-asserted-by":"publisher","first-page":"e507","DOI":"10.1016\/S2665-9913(24)00117-6","volume":"6","author":"GBD 2021 Gout Collaborators","year":"2024","unstructured":"GBD 2021 Gout Collaborators. Global, regional, and National burden of gout, 1990\u20132020, and projections to 2050: a systematic analysis of the global burden of disease study 2021. Lancet Rheumatol. 2024;6:e507\u201317.","journal-title":"Lancet Rheumatol"},{"key":"1199_CR15","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1136\/annrheumdis-2016-210588","volume":"76","author":"MC Fisher","year":"2017","unstructured":"Fisher MC, Rai SK, Lu N, Zhang Y, Choi HK. The unclosing premature mortality gap in gout: a general population-based study. Ann Rheum Dis. 2017;76:1289\u201394.","journal-title":"Ann Rheum Dis"},{"key":"1199_CR16","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1748-5908-7-50","volume":"7","author":"JM Grimshaw","year":"2012","unstructured":"Grimshaw JM, Eccles MP, Lavis JN, Hill SJ, Squires JE. Knowledge translation of research findings. Implement Sci IS. 2012;7:50.","journal-title":"Implement Sci IS"},{"key":"1199_CR17","doi-asserted-by":"publisher","first-page":"642","DOI":"10.7326\/0003-4819-135-8_Part_2-200110161-00002","volume":"135","author":"NS Wenger","year":"2001","unstructured":"Wenger NS, Shekelle PG. Assessing care of vulnerable elders: ACOVE project overview. Ann Intern Med. 2001;135:642\u20136.","journal-title":"Ann Intern Med"},{"key":"1199_CR18","doi-asserted-by":"crossref","unstructured":"Donabedian A. Evaluating the quality of medical care. 1966. Milbank Q. 2005;83:691\u2013729.","DOI":"10.1111\/j.1468-0009.2005.00397.x"},{"key":"1199_CR19","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/1529-0131(199610)9:5<339::AID-ANR1790090502>3.0.CO;2-M","volume":"9","author":"T Pincus","year":"1996","unstructured":"Pincus T. Documenting quality management in rheumatic disease: are patient questionnaires the best (and only) method? Arthritis Care Res. 1996;9:339\u201348.","journal-title":"Arthritis Care Res"},{"key":"1199_CR20","doi-asserted-by":"publisher","first-page":"653","DOI":"10.7326\/0003-4819-135-8_Part_2-200110161-00004","volume":"135","author":"PG Shekelle","year":"2001","unstructured":"Shekelle PG, MacLean CH, Morton SC, Wenger NS. Acove quality indicators. Ann Intern Med. 2001;135:653\u201367.","journal-title":"Ann Intern Med"},{"key":"1199_CR21","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1002\/art.20102","volume":"50","author":"TR Mikuls","year":"2004","unstructured":"Mikuls TR, MacLean CH, Olivieri J, Patino F, Allison JJ, Farrar JT, et al. Quality of care indicators for gout management. Arthritis Rheum. 2004;50:937\u201343.","journal-title":"Arthritis Rheum"},{"key":"1199_CR22","doi-asserted-by":"crossref","unstructured":"Kwok TSH, Kuriya B, Hawker G, Eder L, Li P, Choy G et al. Adherence and Treat-to-Target benchmarks in older adults with gout initiating Urate-Lowering therapy in ontario, canada: A Population-Based study. Arthritis Care Res. 2024; 76:1379-1389 https:\/\/pubmed.ncbi.nlm.nih.gov\/38831665\/","DOI":"10.1002\/acr.25380"},{"key":"1199_CR23","doi-asserted-by":"crossref","unstructured":"Kwok TSH, Kuriya B, Hawker G, Li P, Choy G, Widdifield J. Serum urate monitoring among older adults with gout: initiating urate-Lowering therapy in ontario, Canada. Arthritis Care Res. 2023;75:2463-2471. https:\/\/pubmed.ncbi.nlm.nih.gov\/37248652\/","DOI":"10.1002\/acr.25167"},{"key":"1199_CR24","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/art.22767","volume":"57","author":"JA Singh","year":"2007","unstructured":"Singh JA, Hodges JS, Toscano JP, Asch SM. Quality of care for gout in the US needs improvement. Arthritis Rheum. 2007;57:822\u20139.","journal-title":"Arthritis Rheum"},{"key":"1199_CR25","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1093\/rheumatology\/keh679","volume":"44","author":"TR Mikuls","year":"2005","unstructured":"Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Saag KG. Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results from the UK general practice research database (GPRD). Rheumatol Oxf Engl. 2005;44:1038\u201342.","journal-title":"Rheumatol Oxf Engl"},{"key":"1199_CR26","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/acr.20369","volume":"63","author":"KG Saag","year":"2011","unstructured":"Saag KG, Yazdany J, Alexander C, Caplan L, Coblyn J, Desai SP, et al. Defining quality of care in rheumatology: the American college of rheumatology white paper on quality measurement. Arthritis Care Res. 2011;63:2\u20139.","journal-title":"Arthritis Care Res"},{"key":"1199_CR27","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1002\/acr.23500","volume":"70","author":"JD FitzGerald","year":"2018","unstructured":"FitzGerald JD, Mikuls TR, Neogi T, Singh JA, Robbins M, Khanna PP, et al. Development of the American college of rheumatology electronic clinical quality measures for gout. Arthritis Care Res. 2018;70:659\u201371.","journal-title":"Arthritis Care Res"},{"key":"1199_CR28","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1002\/acr.23089","volume":"68","author":"J Yazdany","year":"2016","unstructured":"Yazdany J, Bansback N, Clowse M, Collier D, Law K, Liao KP, et al. Rheumatology informatics system for effectiveness: A National informatics-Enabled registry for quality improvement. Arthritis Care Res. 2016;68:1866\u201373.","journal-title":"Arthritis Care Res"},{"key":"1199_CR29","doi-asserted-by":"publisher","first-page":"58","DOI":"10.7326\/M16-0570","volume":"166","author":"A Qaseem","year":"2017","unstructured":"Qaseem A, Harris RP, Forciea MA, Clinical Guidelines Committee of the American College of Physicians, Denberg TD, Barry MJ, et al. Management of acute and recurrent gout: A clinical practice guideline from the American college of physicians. Ann Intern Med. 2017;166:58\u201368.","journal-title":"Ann Intern Med"},{"key":"1199_CR30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","volume":"76","author":"P Richette","year":"2017","unstructured":"Richette P, Doherty M, Pascual E, Barskova V, Becce F, Casta\u00f1eda-Sanabria J, et al. 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis. 2017;76:29\u201342.","journal-title":"Ann Rheum Dis"},{"key":"1199_CR31","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/rheumatology\/kex156","volume":"56","author":"M Hui","year":"2017","unstructured":"Hui M, Carr A, Cameron S, Davenport G, Doherty M, Forrester H, et al. The British society for rheumatology guideline for the management of gout. Rheumatol Oxf Engl. 2017;56:e1\u201320.","journal-title":"Rheumatol Oxf Engl"},{"key":"1199_CR32","doi-asserted-by":"publisher","first-page":"7616","DOI":"10.3390\/jcm13247616","volume":"13","author":"J Timsans","year":"2024","unstructured":"Timsans J, Palom\u00e4ki A, Kauppi M. Gout and hyperuricemia: A narrative review of their comorbidities and clinical implications. J Clin Med. 2024;13:7616.","journal-title":"J Clin Med"},{"key":"1199_CR33","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1093\/rheumatology\/kem056a","volume":"46","author":"KM Jordan","year":"2007","unstructured":"Jordan KM, Cameron JS, Snaith M, Zhang W, Doherty M, Seckl J, et al. British society for rheumatology and British health professionals in rheumatology guideline for the management of gout. Rheumatol Oxf Engl. 2007;46:1372\u20134.","journal-title":"Rheumatol Oxf Engl"},{"key":"1199_CR34","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1136\/ard.2006.055269","volume":"65","author":"W Zhang","year":"2006","unstructured":"Zhang W, Doherty M, Bardin T, Pascual E, Barskova V, Conaghan P, et al. EULAR evidence based recommendations for gout. Part II: management. Report of a task force of the EULAR standing committee for international clinical studies including therapeutics (ESCISIT). Ann Rheum Dis. 2006;65:1312\u201324.","journal-title":"Ann Rheum Dis"},{"key":"1199_CR35","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/acr.24180","volume":"72","author":"JD FitzGerald","year":"2020","unstructured":"FitzGerald JD, Dalbeth N, Mikuls T, Brignardello-Petersen R, Guyatt G, Abeles AM, et al. 2020 American college of rheumatology guideline for the management of gout. Arthritis Care Res. 2020;72:744\u201360.","journal-title":"Arthritis Care Res"},{"key":"1199_CR36","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1001\/jama.2023.26640","volume":"331","author":"N McCormick","year":"2024","unstructured":"McCormick N, Yokose C, Challener GJ, Joshi AD, Tanikella S, Choi HK. Serum urate and recurrent gout. JAMA. 2024;331:417\u201324.","journal-title":"JAMA"},{"key":"1199_CR37","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.amjmed.2012.05.025","volume":"125","author":"TH Taylor","year":"2012","unstructured":"Taylor TH, Mecchella JN, Larson RJ, Kerin KD, Mackenzie TA. Initiation of allopurinol at first medical contact for acute attacks of gout: a randomized clinical trial. Am J Med. 2012;125:1126\u2013e11347.","journal-title":"Am J Med"},{"key":"1199_CR38","first-page":"120","volume":"21","author":"EM Hill","year":"2015","unstructured":"Hill EM, Sky K, Sit M, Collamer A, Higgs J. Does starting allopurinol prolong acute treated gout? A randomized clinical trial. J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis. 2015;21:120\u20135.","journal-title":"J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis"},{"key":"1199_CR39","first-page":"48","volume":"122","author":"P Densen","year":"2011","unstructured":"Densen P. Challenges and opportunities facing medical education. Trans Am Clin Climatol Assoc. 2011;122:48\u201358.","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"1199_CR40","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1136\/annrheumdis-2015-208237","volume":"74","author":"T Neogi","year":"2015","unstructured":"Neogi T, Jansen TLTA, Dalbeth N, Fransen J, Schumacher HR, Berendsen D, et al. 2015 gout classification criteria: an American college of rheumatology\/european league against rheumatism collaborative initiative. Ann Rheum Dis. 2015;74:1789\u201398.","journal-title":"Ann Rheum Dis"},{"key":"1199_CR41","doi-asserted-by":"publisher","first-page":"E171","DOI":"10.1503\/cmaj.201392","volume":"193","author":"TSH Kwok","year":"2021","unstructured":"Kwok TSH, Xu VYY, Lake SL, Gout. CMAJ Can Med Assoc J J Assoc Medicale Can. 2021;193:E171.","journal-title":"CMAJ Can Med Assoc J J Assoc Medicale Can"},{"key":"1199_CR42","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1002\/pds.4044","volume":"25","author":"LA MacFarlane","year":"2016","unstructured":"MacFarlane LA, Liu C-C, Solomon DH, Kim SC. Validation of claims-based algorithms for gout flares. Pharmacoepidemiol Drug Saf. 2016;25:820\u20136.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1199_CR43","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/art.22474","volume":"57","author":"LR Harrold","year":"2007","unstructured":"Harrold LR, Saag KG, Yood RA, Mikuls TR, Andrade SE, Fouayzi H, et al. Validity of gout diagnoses in administrative data. Arthritis Rheum. 2007;57:103\u20138.","journal-title":"Arthritis Rheum"},{"key":"1199_CR44","doi-asserted-by":"publisher","first-page":"R224","DOI":"10.1186\/ar4425","volume":"15","author":"JA Singh","year":"2013","unstructured":"Singh JA. Veterans affairs databases are accurate for gout-related health care utilization: a validation study. Arthritis Res Ther. 2013;15:R224.","journal-title":"Arthritis Res Ther"},{"key":"1199_CR45","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.3899\/jrheum.180989","volume":"46","author":"M Dehlin","year":"2019","unstructured":"Dehlin M, Landgren AJ, Bergsten U, Jacobsson LTH. The validity of gout diagnosis in primary care: results from a patient survey. J Rheumatol. 2019;46:1531\u20134.","journal-title":"J Rheumatol"},{"key":"1199_CR46","doi-asserted-by":"publisher","first-page":"e2142347","DOI":"10.1001\/jamanetworkopen.2021.42347","volume":"5","author":"TR Mikuls","year":"2022","unstructured":"Mikuls TR, Soto Q, Petro A, Helget L, Roul P, Sayles H, et al. Comparison of rates of lower extremity amputation in patients with and without gout in the US department of veterans affairs health system. JAMA Netw Open. 2022;5:e2142347.","journal-title":"JAMA Netw Open"},{"key":"1199_CR47","first-page":"41","volume":"3","author":"S Bowen","year":"2008","unstructured":"Bowen S, Kreindler SA. Indicator madness: a cautionary reflection on the use of indicators in healthcare. Healthc Policy Polit Sante. 2008;3:41\u20138.","journal-title":"Healthc Policy Polit Sante"},{"key":"1199_CR48","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41584-021-00657-4","volume":"17","author":"LK Stamp","year":"2021","unstructured":"Stamp LK, Farquhar H, Pisaniello HL, Vargas-Santos AB, Fisher M, Mount DB, et al. Management of gout in chronic kidney disease: a G-CAN consensus statement on the research priorities. Nat Rev Rheumatol. 2021;17:633\u201341.","journal-title":"Nat Rev Rheumatol"},{"key":"1199_CR49","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1016\/S0140-6736(21)00569-9","volume":"397","author":"N Dalbeth","year":"2021","unstructured":"Dalbeth N, Gosling AL, Gaffo A, Abhishek A, Gout. Lancet Lond Engl. 2021;397:1843\u201355.","journal-title":"Lancet Lond Engl"},{"key":"1199_CR50","doi-asserted-by":"publisher","first-page":"504","DOI":"10.3899\/jrheum.140588","volume":"42","author":"N Rashid","year":"2015","unstructured":"Rashid N, Coburn BW, Wu Y-L, Cheetham TC, Curtis JR, Saag KG, et al. Modifiable factors associated with allopurinol adherence and outcomes among patients with gout in an integrated healthcare system. J Rheumatol. 2015;42:504\u201312.","journal-title":"J Rheumatol"},{"key":"1199_CR51","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1111\/1756-185X.13032","volume":"20","author":"EJM Corbett","year":"2017","unstructured":"Corbett EJM, Pentony P, McGill NW. Achieving serum urate targets in gout: an audit in a gout-oriented rheumatology practice. Int J Rheum Dis. 2017;20:894\u20137.","journal-title":"Int J Rheum Dis"},{"key":"1199_CR52","doi-asserted-by":"publisher","first-page":"e281","DOI":"10.1016\/S2665-9913(20)30029-1","volume":"2","author":"JA Singh","year":"2020","unstructured":"Singh JA, Richman J, Yang S, Bridges SL, Saag K. Allopurinol adherence and its predictors in gout: a National cohort study in US veterans. Lancet Rheumatol. 2020;2:e281\u201391.","journal-title":"Lancet Rheumatol"},{"key":"1199_CR53","first-page":"562","volume":"33","author":"TR Mikuls","year":"2006","unstructured":"Mikuls TR, Curtis JR, Allison JJ, Hicks RW, Saag KG. Medication errors with the use of allopurinol and colchicine: a retrospective study of a national, anonymous Internet-accessible error reporting system. J Rheumatol. 2006;33:562\u20136.","journal-title":"J Rheumatol"},{"key":"1199_CR54","doi-asserted-by":"publisher","first-page":"117","DOI":"10.15386\/mpr-1201","volume":"92","author":"LA Anghel","year":"2019","unstructured":"Anghel LA, Farcas AM, Oprean RN. An overview of the common methods used to measure treatment adherence. Med Pharm Rep. 2019;92:117\u201322.","journal-title":"Med Pharm Rep"},{"key":"1199_CR55","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1002\/acr.22638","volume":"67","author":"M Bonafede","year":"2015","unstructured":"Bonafede M, Johnson BH, Tang DH, Shah N, Harrison DJ, Collier DH. Etanercept-Methotrexate combination therapy initiators have greater adherence and persistence than triple therapy initiators with rheumatoid arthritis. Arthritis Care Res. 2015;67:1656\u201363.","journal-title":"Arthritis Care Res"},{"key":"1199_CR56","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1524-4733.2007.00213.x","volume":"11","author":"JA Cramer","year":"2008","unstructured":"Cramer JA, Roy A, Burrell A, Fairchild CJ, Fuldeore MJ, Ollendorf DA, et al. Medication compliance and persistence: terminology and definitions. Value Health J Int Soc Pharmacoeconomics Outcomes Res. 2008;11:44\u20137.","journal-title":"Value Health J Int Soc Pharmacoeconomics Outcomes Res"},{"key":"1199_CR57","first-page":"44","volume":"21","author":"RP McDonough","year":"2015","unstructured":"McDonough RP. Identifying and resolving medication nonadherence. Pharm Today. 2015;21:44.","journal-title":"Pharm Today"},{"key":"1199_CR58","doi-asserted-by":"publisher","first-page":"e017542","DOI":"10.1136\/bmjopen-2017-017542","volume":"8","author":"R Yin","year":"2018","unstructured":"Yin R, Li L, Zhang G, Cui Y, Zhang L, Zhang Q, et al. Rate of adherence to urate-lowering therapy among patients with gout: a systematic review and meta-analysis. BMJ Open. 2018;8:e017542.","journal-title":"BMJ Open"},{"key":"1199_CR59","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1002\/acr.22336","volume":"66","author":"MA De Vera","year":"2014","unstructured":"De Vera MA, Marcotte G, Rai S, Galo JS, Bhole V. Medication adherence in gout: a systematic review. Arthritis Care Res. 2014;66:1551\u20139.","journal-title":"Arthritis Care Res"},{"key":"1199_CR60","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/art.20405","volume":"51","author":"A Shoji","year":"2004","unstructured":"Shoji A, Yamanaka H, Kamatani N. A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy. Arthritis Rheum. 2004;51:321\u20135.","journal-title":"Arthritis Rheum"},{"key":"1199_CR61","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1136\/annrheumdis-2021-220439","volume":"80","author":"R Koto","year":"2021","unstructured":"Koto R, Nakajima A, Horiuchi H, Yamanaka H. Serum uric acid control for prevention of gout flare in patients with asymptomatic hyperuricaemia: a retrospective cohort study of health insurance claims and medical check-up data in Japan. Ann Rheum Dis. 2021;80:1483\u201390.","journal-title":"Ann Rheum Dis"},{"key":"1199_CR62","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1002\/acr.25009","volume":"75","author":"N Hammam","year":"2023","unstructured":"Hammam N, Li J, Kay J, Izadi Z, Yazdany J, Schmajuk G. Monitoring and achievement of target serum urate among gout patients receiving Long-Term urate-Lowering therapy in the American college of rheumatology RISE registry. Arthritis Care Res. 2023;75:1544\u201352.","journal-title":"Arthritis Care Res"},{"key":"1199_CR63","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.semarthrit.2021.04.011","volume":"51","author":"C-N Son","year":"2021","unstructured":"Son C-N, Stewart S, Su I, Mihov B, Gamble G, Dalbeth N. Global patterns of treat-to-serum urate target care for gout: systematic review and meta-analysis. Semin Arthritis Rheum. 2021;51:677\u201384.","journal-title":"Semin Arthritis Rheum"},{"key":"1199_CR64","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3899\/jrheum.190522","volume":"47","author":"JA Singh","year":"2020","unstructured":"Singh JA, Yang S, Saag KG. Factors influencing the effectiveness of allopurinol in achieving and sustaining target serum urate in a US veterans affairs gout cohort. J Rheumatol. 2020;47:449\u201360.","journal-title":"J Rheumatol"},{"key":"1199_CR65","doi-asserted-by":"crossref","unstructured":"Helget LN, O\u2019Dell JR, Newcomb JA, Androsenko M, Brophy MT, Davis-Karim A et al. Determinants of achieving serum urate goal with Treat-to-Target urate-Lowering therapy in gout. Arthritis Rheumatol Hoboken NJ. 2024;76:638-646. https:\/\/pubmed.ncbi.nlm.nih.gov\/37842953\/","DOI":"10.1002\/art.42731"},{"key":"1199_CR66","first-page":"347","volume":"30","author":"J Hibbard","year":"2004","unstructured":"Hibbard J, Pawlson LG. Why not give consumers a framework for Understanding quality? Jt Comm J Qual Saf. 2004;30:347\u201351.","journal-title":"Jt Comm J Qual Saf"},{"key":"1199_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2307\/2137284","volume":"36","author":"RM Andersen","year":"1995","unstructured":"Andersen RM. Revisiting the behavioral model and access to medical care: does it matter? J Health Soc Behav. 1995;36:1\u201310.","journal-title":"J Health Soc Behav"},{"key":"1199_CR68","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1547-5069.1998.tb01234.x","volume":"30","author":"PH Mitchell","year":"1998","unstructured":"Mitchell PH, Ferketich S, Jennings BM. Quality health outcomes model. American academy of nursing expert panel on quality health care. Image\u2013 J Nurs Scholarsh. 1998;30:43\u20136.","journal-title":"Image\u2013 J Nurs Scholarsh"},{"key":"1199_CR69","first-page":"383","volume":"52","author":"K Alfeld","year":"2025","unstructured":"Alfeld K, Barclay ML, McNeill R, Frampton C, Doogue M, Stamp LK. Inpatient management of gout: serum urate testing and allopurinol dose adjustment. J Rheumatol. 2025;52:383\u20138.","journal-title":"J Rheumatol"},{"key":"1199_CR70","first-page":"1295","volume":"18","author":"G Desideri","year":"2014","unstructured":"Desideri G, Castaldo G, Lombardi A, Mussap M, Testa A, Pontremoli R, et al. Is it time to revise the normal range of serum uric acid levels? Eur Rev Med Pharmacol Sci. 2014;18:1295\u2013306.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1199_CR71","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s42358-022-00246-3","volume":"62","author":"M D\u00f3rio","year":"2022","unstructured":"D\u00f3rio M, Bense\u00f1or IM, Lotufo P, Santos IS, Fuller R. Reference range of serum uric acid and prevalence of hyperuricemia: a cross-sectional study from baseline data of ELSA-Brasil cohort. Adv Rheumatol Lond Engl. 2022;62:15.","journal-title":"Adv Rheumatol Lond Engl"},{"key":"1199_CR72","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s10067-015-3039-2","volume":"35","author":"P Chandratre","year":"2016","unstructured":"Chandratre P, Mallen CD, Roddy E, Liddle J, Richardson J. You want to get on with the rest of your life: a qualitative study of health-related quality of life in gout. Clin Rheumatol. 2016;35:1197\u2013205.","journal-title":"Clin Rheumatol"},{"key":"1199_CR73","doi-asserted-by":"publisher","first-page":"e10452","DOI":"10.1002\/lrh2.10452","volume":"9","author":"L Shaw","year":"2025","unstructured":"Shaw L, Perrier M, Tahmasebian K, Wong K, Yajnik P, Zhu Z, et al. Developing a codebook to characterize barriers, enablers, and strategies for implementing learning health systems from a multilevel perspective. Learn Health Syst. 2025;9:e10452.","journal-title":"Learn Health Syst"},{"key":"1199_CR74","doi-asserted-by":"crossref","unstructured":"Subash M, Liu LH, DeQuattro K, Choden S, Jacobsohn L, Katz P, et al. The development of the rheumatology informatics system for effectiveness learning collaborative for improving Patient-Reported outcome collection and Patient-Centered communication in adult rheumatology. ACR Open Rheumatol; 2021.","DOI":"10.1002\/acr2.11310"},{"key":"1199_CR75","unstructured":"Githumbi R, Barber CEH, Bartlett SJ, Toupin-April K, Twilt M, Lacaille D et al. Canadian rheumatology association guidance for developing & endorsing quality measures to support learning health systems. J Rheumatol. 2025;jrheum.2024\u2013\u20091065. https:\/\/pubmed.ncbi.nlm.nih.gov\/40233996\/"},{"key":"1199_CR76","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.semarthrit.2016.08.006","volume":"46","author":"SK Rai","year":"2017","unstructured":"Rai SK, Avi\u00f1a-Zubieta JA, McCormick N, De Vera MA, Shojania K, Sayre EC, et al. The rising prevalence and incidence of gout in British columbia, canada: Population-based trends from 2000 to 2012. Semin Arthritis Rheum. 2017;46:451\u20136.","journal-title":"Semin Arthritis Rheum"},{"key":"1199_CR77","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1007\/s10067-023-06532-9","volume":"42","author":"TSH Kwok","year":"2023","unstructured":"Kwok TSH, Widdifield J. Improving access to care for rheumatology services in Canada. Clin Rheumatol. 2023;42:1205\u201311.","journal-title":"Clin Rheumatol"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-025-01199-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11926-025-01199-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-025-01199-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T19:04:12Z","timestamp":1770750252000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11926-025-01199-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,30]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1199"],"URL":"https:\/\/doi.org\/10.1007\/s11926-025-01199-4","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,30]]},"assertion":[{"value":"25 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research ethics board at the Sunnybrook Health Sciences Centre determined that this study does not meet the definition of research and approval is not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"32"}}